Cargando…

Gut microbiota in patients with obesity and metabolic disorders — a systematic review

BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and popula...

Descripción completa

Detalles Bibliográficos
Autores principales: XU, Zhilu, JIANG, Wei, HUANG, Wenli, LIN, Yu, CHAN, Francis K.L., NG, Siew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903526/
https://www.ncbi.nlm.nih.gov/pubmed/35093025
http://dx.doi.org/10.1186/s12263-021-00703-6
_version_ 1784664756642119680
author XU, Zhilu
JIANG, Wei
HUANG, Wenli
LIN, Yu
CHAN, Francis K.L.
NG, Siew C.
author_facet XU, Zhilu
JIANG, Wei
HUANG, Wenli
LIN, Yu
CHAN, Francis K.L.
NG, Siew C.
author_sort XU, Zhilu
collection PubMed
description BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and populations. METHODS: We performed a systematic search of MEDLINE (OvidSP) and Embase (OvidSP) of articles published from Sept 1, 2010, to July 10, 2021, for case–control studies comparing intestinal microbiome of individuals with obesity and metabolic disorders with the microbiome of non-obese, metabolically healthy individuals (controls). The primary outcome was bacterial taxonomic changes in patients with obesity and metabolic disorders as compared to controls. Taxa were defined as “lean-associated” if they were depleted in patients with obesity and metabolic disorders or negatively associated with abnormal metabolic parameters. Taxa were defined as “obesity-associated” if they were enriched in patients with obesity and metabolic disorders or positively associated with abnormal metabolic parameters. RESULTS: Among 2390 reports screened, we identified 110 full-text articles and 60 studies were included. Proteobacteria was the most consistently reported obesity-associated phylum. Thirteen, nine, and ten studies, respectively, reported Faecalibacterium, Akkermansia, and Alistipes as lean-associated genera. Prevotella and Ruminococcus were obesity-associated genera in studies from the West but lean-associated in the East. Roseburia and Bifidobacterium were lean-associated genera only in the East, whereas Lactobacillus was an obesity-associated genus in the West. CONCLUSIONS: We identified specific bacteria associated with obesity and metabolic disorders in western and eastern populations. Mechanistic studies are required to determine whether these microbes are a cause or product of obesity and metabolic disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12263-021-00703-6.
format Online
Article
Text
id pubmed-8903526
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89035262022-03-18 Gut microbiota in patients with obesity and metabolic disorders — a systematic review XU, Zhilu JIANG, Wei HUANG, Wenli LIN, Yu CHAN, Francis K.L. NG, Siew C. Genes Nutr Review BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and populations. METHODS: We performed a systematic search of MEDLINE (OvidSP) and Embase (OvidSP) of articles published from Sept 1, 2010, to July 10, 2021, for case–control studies comparing intestinal microbiome of individuals with obesity and metabolic disorders with the microbiome of non-obese, metabolically healthy individuals (controls). The primary outcome was bacterial taxonomic changes in patients with obesity and metabolic disorders as compared to controls. Taxa were defined as “lean-associated” if they were depleted in patients with obesity and metabolic disorders or negatively associated with abnormal metabolic parameters. Taxa were defined as “obesity-associated” if they were enriched in patients with obesity and metabolic disorders or positively associated with abnormal metabolic parameters. RESULTS: Among 2390 reports screened, we identified 110 full-text articles and 60 studies were included. Proteobacteria was the most consistently reported obesity-associated phylum. Thirteen, nine, and ten studies, respectively, reported Faecalibacterium, Akkermansia, and Alistipes as lean-associated genera. Prevotella and Ruminococcus were obesity-associated genera in studies from the West but lean-associated in the East. Roseburia and Bifidobacterium were lean-associated genera only in the East, whereas Lactobacillus was an obesity-associated genus in the West. CONCLUSIONS: We identified specific bacteria associated with obesity and metabolic disorders in western and eastern populations. Mechanistic studies are required to determine whether these microbes are a cause or product of obesity and metabolic disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12263-021-00703-6. BioMed Central 2022-01-29 /pmc/articles/PMC8903526/ /pubmed/35093025 http://dx.doi.org/10.1186/s12263-021-00703-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
XU, Zhilu
JIANG, Wei
HUANG, Wenli
LIN, Yu
CHAN, Francis K.L.
NG, Siew C.
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
title Gut microbiota in patients with obesity and metabolic disorders — a systematic review
title_full Gut microbiota in patients with obesity and metabolic disorders — a systematic review
title_fullStr Gut microbiota in patients with obesity and metabolic disorders — a systematic review
title_full_unstemmed Gut microbiota in patients with obesity and metabolic disorders — a systematic review
title_short Gut microbiota in patients with obesity and metabolic disorders — a systematic review
title_sort gut microbiota in patients with obesity and metabolic disorders — a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903526/
https://www.ncbi.nlm.nih.gov/pubmed/35093025
http://dx.doi.org/10.1186/s12263-021-00703-6
work_keys_str_mv AT xuzhilu gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview
AT jiangwei gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview
AT huangwenli gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview
AT linyu gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview
AT chanfranciskl gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview
AT ngsiewc gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview